Breast cancer plus adjuvant chemotherapy- related cognitive impairment: a case study

References

• Ahles, T., & Saykin, A. (2007). Candidate mechanisms for chemotherapy-induced cognitive changes. Nature Reviews Cancer, 7, 192–201. doi:10.1038/nrc2073.
   PubMed Web of Science ®Google Scholar
• Ahles, T. A., Root, J., & Ryan, E. (2012). Cancer- and cancer treatment–Associated cognitive change: An update on the state of the science. Journal of Clinical Oncology, 30, 3675–3686. doi:10.1200/jco.2012.43.0116.
   PubMed Web of Science ®Google Scholar
• Ahles, T. A., Saykin, A. J., Furstenberg, C. T., Cole, B., Mott, L. A., Skalla, K., … Silberfarb, P. M. (2002). Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. Journal of Clinical Oncology, 20, 485–493. doi:10.1200/jco.2002.20.2.485.
   PubMed Web of Science ®Google Scholar
• Andreotti, C, Root, J, Schagen, S, McDonald, B, Saykin, A, Atkinson, T, & Ahles, T. (2016). Reliable change in neuropsychological assessment of breast cancer survivors. Psycho-oncology, 25, 43–50. doi: 10.1002/pon.3799
   PubMed Web of Science ®Google Scholar
• Bedillion, M., Ansell, E., & Thomas, G. (2019). Cancer treatment effects on cognition and depression: The moderating role of physical activity. Breast, 44, 73–80. doi:10.1016/j.breast.2019.01.004.
   PubMed Web of Science ®Google Scholar
• Chen, B., Sethi, S., Jin, T., Patel, S., Ye, N., Sun., C., … Hurria, A. (2018). Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: A brain magnetic resonance imaging pilot study. Breast Cancer Research, 20, 38. doi:10.1186/s13058-018-0965-3.
   PubMed Web of Science ®Google Scholar
• Chen, X., He, X., Tao, L., Cheng, H., Li, J., Zhang, J., … Wang, K. (2017). The attention network changes in breast cancer patients receiving neoadjuvant chemotherapy: Evidence from an arterial spin labeling perfusion study. Scientific Reports, 7, 42684. doi:10.1038/srep42684.
   PubMed Web of Science ®Google Scholar
• De Ruiter, M., Reneman, L., Boogerd, W., Veltman, D., Van Dam, F., Nederveen, A., … Schagen, S. (2011). Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Human Brain Mapping, 32, 1206–1219. doi:10.1002/hbm.21102.
   PubMed Web of Science ®Google Scholar
• Deprez, S., Amant, F., Smeets, A., Peeters, R., Leemans, A., Van Hecke, W., … Sunaert, S. (2012). Longitudinal assessment of chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning. Journal of Clinical Oncology, 30, 274–281. doi:10.1200/JCO.2011.36.8571.
   PubMed Web of Science ®Google Scholar
• Ganz, P., Kwan, L., Castellon, S., Oppenheim, A., Bower, J., Silverman, D., … Belin, T. (2013). Cognitive complaints after breast cancer treatments: Examining the relationship with neuropsychological test performance. JNCI: Journal of the National Cancer Institute, 105, 791–801. doi:10.1093/jnci/djt073.
   PubMedGoogle Scholar
• Heinesen, E., Imai, S., & Maruyama, S. (2018). Employment, job skills and occupational mobility of cancer survivors. Journal of Health Economics, 58, 151–175. doi:10.1016/j.jhealeco.2018.01.006.
   PubMed Web of Science ®Google Scholar
• Hermelink, K. (2015). Chemotherapy and cognitive function in breast cancer patients: The so-called chemo brain. JNCI Monographs, 2015, 67–69. doi:10.1093/jncimonographs/lgv009.
   Google Scholar
• Iverson, G. (2001). Interpreting change on the WAIS-III/WMS-III in clinical samples. Archives of Clinical Neuropsychology, 16, 183–191.
   PubMed Web of Science ®Google Scholar
• Janelsins, M., Kessler, S., Ahles, T., & Morrow, G. (2014). Prevalence, mechanisms and management of cancer related cognitive impairment. International Review of Psychiatry, 26, 102–113. doi:10.3109/09540261.2013.864260.
   PubMed Web of Science ®Google Scholar
• Kesler, S., Bennett, C., Mahaffey, M., & Spiegel, D. (2009). Regional brain activation during verbal declarative memory in metastatic brain cancer. Clinical Cancer Research, 15, 6665–6673. doi:10.1158/1078-0432.CCR-09-1227.
   PubMed Web of Science ®Google Scholar
• Kesler, S., Wefel, J., Hosseini, S., Cheung, M., Watson, C., & Hoeft, F. (2013). Default mode network connectivity distinguishes chemotherapy-treated breast cancer survivors from controls. Proceedings of the National Academy of Sciences, 110, 11600–11605. doi:10.1073/pnas.1214551110.
   PubMed Web of Science ®Google Scholar
• Koppelmans, V., Bretzler, M., Boogerd, W., Seynaeve, C., Gundy, C., & Schagen, S. (2012). Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy. Journal of Clinical Oncology, 30, 1080–1086. doi:10.1200/JCO.2011.37.0189.
   PubMed Web of Science ®Google Scholar
• Kvale, E., Clay, O., Ross-Meadows, L., McGee, J., Edwards, J., Unverzagt, F., & Ball, K. (2010). Cognitive speed of processing and functional declines in older cancer survivors: An analysis of data from the ACTIVE trial. European Journal of Cancer Care, 19, 110–117. doi:10.1111/j.1365-2354.2008.01018.x.
   PubMed Web of Science ®Google Scholar
• Lepage, C., Smith, A., Moreau, J., Barlow-Krelina, E., Wallis, N., Collins, B., … Scherling, C. (2014). A prospective study of grey matter and cognitive function alterations in chemotherapy-treated breast cancer patients. SpringerPlus, 3, 444. doi:10.1186/2193-1801-3-444.
   PubMedGoogle Scholar
• McDonald, B., Conroy, S., Ahles, T., West, J., & Saykin, A. (2010). Gray matter reduction associated with systemic chemotherapy for breast cancer: A prospective MRI study. Breast Cancer Research and Treatment, 123, 819–828. doi:10.1007/s10549-010-1088-4.
   PubMed Web of Science ®Google Scholar
• McDonald, B., Conroy, S., Ahles, T., West, J., & Saykin, A. (2012). Alterations in brain activation during working memory processing associated with breast cancer and treatment: A prospective functional magnetic resonance imaging study. Journal of Clinical Oncolology, 30, 2500–2508. doi:10.1200/JCO.2011.38.5674.
   PubMed Web of Science ®Google Scholar
• McDonald, B., & Saykin, A. (2013). Alterations in brain structure related to breast cancer and its treatment: Chemotherapy and other considerations. Brain Imaging and Behavior, 7, 374–387. doi:10.1007/s11682-013-9256-x.
   PubMed Web of Science ®Google Scholar
• Mehnert, A. (2011). Employment and work-related issues in cancer survivors. Critical Reviews in Oncology/Hematology, 77, 109–130. doi:10.1016/j.critrevonc.2010.01.004.
   PubMed Web of Science ®Google Scholar
• Pascal, J. (2010). Management of cancer-related cognitive dysfunction—Conceptualization challenges and implications for clinical research and practice. US Oncolology, 6, 9–12.
   PubMedGoogle Scholar
• Perrier, J., Viard, A., Levy, C., Morel, N., Allouache, D., Noal, S., … Giffard, B. (2018). Longitudinal investigation of cognitive deficits in breast cancer patients and their gray matter correlates: Impact of education level. Brain Imaging and Behavior. doi:10.1007/s11682-018-9991-0
   PubMedGoogle Scholar
• Pomykala, K., Ganz, P., Bower, J., Kwan, L., Castellon, S., Mallam, S., … Silverman, D. (2013). The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer. Brain Imaging and Behavior, 7, 511–523. doi:10.1007/s11682-013-9243-2.
   PubMed Web of Science ®Google Scholar
• Psychological Corporation. (1997). WAIS-III/WMS-III technical manual. San Antonio: Harcourt Brace.
   Google Scholar
• Saykin, A. J., De Ruiter, M., McDonald, B., Deprez, S., & Silverman, D. (2013). Neuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: Current status and recommendations for future research. Brain Imaging and Behavior, 7, 363–373. doi:10.1007/s11682-013-9283-7.
   PubMed Web of Science ®Google Scholar
• Scherling, C., & Smith, A. (2013). Opening up the window into ‘Chemobrain’: A neuroimaging review. Sensors, 13, 3169–3203. doi:10.3390/s13030316.
   PubMed Web of Science ®Google Scholar
• Schilder, C., Eggens, P., Seynaeve, C., Linn, S., Boogerd, W., Gundy, C., … Schagen, S. (2009). Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: Cross-sectional findings from the neuropsychological TEAM-side study. Acta Oncologica, 48, 76–85. doi:10.1080/0284186080231473.
   PubMed Web of Science ®Google Scholar
• Vardy, J., Wefel, J., Ahles, T., Tannock, I., & Schagen, S. (2008). Cancer and cancer-therapy related cognitive dysfunction: An international perspective from the Venice cognitive workshop. Annals of Oncology, 19, 623–629. doi:10.1093/annonc/mdm500.
   PubMed Web of Science ®Google Scholar
• Wang, X., Walitt, B., Saligan, L., Tiwari, A., Cheung, C., & Zhang, Z. (2015). Chemobrain: A critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy. Cytokine, 72, 86–96. doi:10.1016/j.cyto.2014.12.006.
   PubMed Web of Science ®Google Scholar
• Wefel, J., Saleeba, A., Buzdar, A., & Meyers, C. (2010). Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer, 116, 3348–3356. doi:10.1002/cncr.25098.
   PubMed Web of Science ®Google Scholar
• Wefel, J. S, Kesler, S. R, Noll, K. R, & Schagen, S. B. (2015). Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults. Ca: a Cancer Journal for Clinicians, 65, 123–138. doi: 10.3322/caac.21258
   PubMed Web of Science ®Google Scholar